About Que Pharma Private Limited
Data last updated:
Que Pharma Private Limited is a private limited company based in Surendranagar, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1995PTC027820. Its GSTIN is 24AAACQ0503F1Z6 (Gujarat).
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Rajendrakumar Himatlal Sanghvi and Dilip Durlabhajibhai Mair.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 2102/A Phase IV GIDC Wadhwan, Surendranagar, Gujarat, India – 363035.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.75 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹9.57 Lakh (net margin 1.2%) and EBITDA of ₹35.08 Lakh (EBITDA margin 4.5%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Quepharma. As per MCA filings, the company has satisfied charges of ₹3.3 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website quepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot No. 2102/A Phase IV GIDC Wadhwan, Surendranagar, Gujarat, India – 363035
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Que Pharma Private Limited
The main business activity of Que Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Que Pharma Private Limited FY 2025 filings available
Que Pharma Private Limited reported revenue of ₹7.75 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Que Pharma Private Limited
Revenue rose 4% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Que Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹35.08 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.57 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Que Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Que Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Que Pharma Private Limited
Que Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Intact Drugs and Pharmaceuticlas Pvt.Ltd. | ₹7.8 Cr (FY 2025) | •••• | •••• | -54.0% | •••• | Delhi, India |
| Solitaire Pharmaceuticals Private Limited | ₹7.79 Cr (FY 2025) | •••• | •••• | 430.0% | •••• | Ahmedabad, Gujarat, India |
| Lexmark Pharmaceuticals Private Limited | ₹7.76 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Unjha, Gujarat, India |
| Clavita Pharma Private Limited | ₹7.76 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Purica Pharmaceuticals Private Limited | ₹7.76 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Kalol, Gujarat, India |
| Que Pharma Private Limited this company | ₹7.75 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Surendranagar, Gujarat, India |
| Chandravardhan Organics Pvt Ltd | ₹7.75 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Solapur, Maharashtra, India |
| Human Bio-Organics Private Limited | ₹7.74 Cr (FY 2024) | •••• | •••• | 42.0% | •••• | Thane, Maharashtra, India |
| Tychos Therapeutics Private Limited | ₹7.74 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Chennai, Tamil Nadu, India |
| Time Remedies Private Limited | ₹7.74 Cr (FY 2023) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Alkon Formulation Private Limited | ₹7.74 Cr (FY 2024) | •••• | •••• | -30.0% | •••• | Baddi, Himachal Pradesh, India |
Peers are the five companies nearest above and the five nearest below Que Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Que Pharma Private Limited
Que Pharma Private Limited is audited by K. C. PARIKH & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| K. C. PARIKH & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Que Pharma Private Limited
Que Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendrakumar Himatlal Sanghvi | Director | 16 Oct 1995 | 30 Years 11 Months | Current |
| Dilip Durlabhajibhai Mair | Director | 16 Oct 1995 | 30 Years 11 Months | Current |
| Jaykantbhai Himatlal Sanghvi | Director | 16 Oct 1995 | 30 Years 11 Months | Current |
Ownership and Shareholding of Que Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Que Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2003 | State Bank of India | ₹1 Cr | Satisfied |
| 31 Mar 2000 | State Bank of India | ₹1 Cr | Satisfied |
| 10 Apr 1997 | State Bank of India | ₹95 Lakh | Satisfied |
| 16 Sep 1996 | State Bank of India | ₹35 Lakh | Satisfied |
Total charge records: 4 View all charges
MSME Payment Delays by Que Pharma Private Limited
Que Pharma Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 132 overdue payments to 27 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 27)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bueno Salud Care (India) Private Limited | •••• | •••• | •••• |
| Skypack Packaging | •••• | •••• | •••• |
| Vital Formulations Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 11 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Que Pharma Private Limited
Que Pharma operates one associated brand: Quepharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical drug manufacturing and contract services in India. | quepharma.com |
Employees and EPFO Compliance at Que Pharma Private Limited
Que Pharma Private Limited has a workforce of 10 employees as of Sep 11, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Que Pharma Private Limited
Que Pharma Private Limited has 3 board changes on record since 1995: 3 appointments. The latest: Dilip Durlabhajibhai Mair was appointed as Director on 16 Oct 1995.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Que Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Que Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Que Pharma Private Limited
Que Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACQ0503F1Z6 | Gujarat | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Que Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Que Pharma Private Limited
Que Pharma is an active private limited company based in Surendranagar, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 October 1995 (31+ years old) and is registered under CIN U24231GJ1995PTC027820.
Que Pharma reported revenue of ₹7.75 Cr for FY 2025 (up 4% YoY).
Que Pharma has 3 current directors:
- Rajendrakumar Himatlal Sanghvi - Director
- Dilip Durlabhajibhai Mair - Director
- Jaykantbhai Himatlal Sanghvi - Director
Que Pharma reported a net profit of ₹9.57 Lakh (net margin 1.2%) and EBITDA of ₹35.08 Lakh (EBITDA margin 4.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Que Pharma is -2% over three years. In the latest year (FY 2025) revenue rose 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Que Pharma is 24AAACQ0503F1Z6, registered in Gujarat.
The CIN (Corporate Identification Number) of Que Pharma is U24231GJ1995PTC027820. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Que Pharma was incorporated on 16 October 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Que Pharma by revenue are Intact Drugs and Pharmaceuticlas Pvt.Ltd, Solitaire Pharmaceuticals Private Limited, Lexmark Pharmaceuticals Private Limited, Clavita Pharma Private Limited, Purica Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Dilip Durlabhajibhai Mair was appointed as Director on 16 Oct 1995. Jaykantbhai Himatlal Sanghvi was appointed as Director on 16 Oct 1995. Rajendrakumar Himatlal Sanghvi was appointed as Director on 16 Oct 1995.
Que Pharma has 11 MSME Form 1 returns on record between 2019 and 2024, listing 132 overdue payments to 27 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Que Pharma can be reached through the website quepharma.com. Its registered office is in Surendranagar, Gujarat, India.